SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-19-000541
Filing Date
2019-02-19
Accepted
2019-02-19 16:28:03
Documents
77
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2237693z10-k.htm 10-K 1493862
2 EX-21.1 a2237693zex-21_1.htm EX-21.1 3853
3 EX-23.1 a2237693zex-23_1.htm EX-23.1 6618
4 EX-31.1 a2237693zex-31_1.htm EX-31.1 8161
5 EX-31.2 a2237693zex-31_2.htm EX-31.2 8150
6 EX-32 a2237693zex-32.htm EX-32 6903
13 G887366.JPG g887366.jpg GRAPHIC 77945
  Complete submission text file 0001047469-19-000541.txt   9255490

Data Files

Seq Description Document Type Size
7 EX-101.INS inva-20181231.xml EX-101.INS 2375332
8 EX-101.SCH inva-20181231.xsd EX-101.SCH 64137
9 EX-101.CAL inva-20181231_cal.xml EX-101.CAL 79886
10 EX-101.DEF inva-20181231_def.xml EX-101.DEF 311813
11 EX-101.LAB inva-20181231_lab.xml EX-101.LAB 640335
12 EX-101.PRE inva-20181231_pre.xml EX-101.PRE 516566
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 19615338
SIC: 2834 Pharmaceutical Preparations